CBSC activates China manufacturing pipeline and advances MyCardia AT into final NMPA submission phase with Ebulent Medical.

Jan 15

Cardiac Biotech

Cardiac Biotech

心脏生物科技解决方案激活MyCardia AT中国生产流程并进入NMPA最终申报阶段

CBSC activates China manufacturing pipeline and enters final NMPA submission phase for MyCardia AT cardiac monitoring device.

CBSC secures Health Canada license for CardioHolter AT with $375K order from Your Heart Protector Corp, expanding cardiac monitoring in Canada.

Sep 25

Cardiac Biotech

Cardiac Biotech

心脏生物科技解决方案获得加拿大卫生部MyCardia AT设备许可证

CBSC secures Health Canada license for CardioHolter AT, lands $375K order with Your Heart Protector Corp, expanding into Canadian market.

CBSC announces $375,000 Noventis Medical purchase order and new recurring revenue program for MyCardia AT cardiac monitoring devices.

Sep 11

Cardiac Biotech

Cardiac Biotech

CBSC宣布37.5万美元采购订单及循环收入项目

CBSC secures $375K purchase order with Noventis Medical and launches recurring revenue program for MyCardia AT devices.

Cardiac Biotech Solutions signs exclusive $600K Noventis Medical distribution agreement for Latin America.

Sep 04

Cardiac Biotech

Cardiac Biotech

心脏生物科技解决方案(CBSC)签署覆盖中美洲和南美洲的独家五年分销协议

Cardiac Biotech Solutions, Inc. signs $600K exclusive distribution deal with Noventis Medical, expanding cardiac monitoring reach into Latin America.

How can we help you?

Tell us what you are interested in.

Contact Us

订阅我们的新闻邮件！

订阅我们的电子报，我们将直接向您发送最新消息。